Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
4-Pyrimidin-5-yl-1,3-dihydroindol-2-one → 2-Methyl-4-[3-(4-methylpiperazin-1-yl)propyl]-5-(2-oxo-4-pyrimidin-5-yl-1,2-dihydroindol-3-ylidenemethyl)-1H-pyrrole-3-carboxylic Acid Ethyl Ester
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | 4-Pyrimidin-5-yl-1,3-dihydroindol-2-one | HCID 22135400 | — |
| 반응물 | 5-formyl-2-methyl-4-[3-(4-methylpiperazin-1-yl)propyl]-1H-pyrrole-3-carboxylic acid ethyl ester | HCID 58779587 | — |
| 생성물 | 2-Methyl-4-[3-(4-methylpiperazin-1-yl)propyl]-5-(2-oxo-4-pyrimidin-5-yl-1,2-dihydroindol-3-ylidenemethyl)-1H-pyrrole-3-carboxylic Acid Ethyl Ester | HCID 69584248 | — |
반응 단계
4-Pyrimidin-5-yl-1,3-dihydroindol-2-one (53 mg, 0.25 mmol) was condensed with 5-formyl-2-methyl-4-[3-(4-methylpiperazin-1-yl)-propyl]-1H-pyrrole-3-carboxylic acid ethyl ester (88 mg, 0.275 mmol) to give the title compound.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US07053086B2 |
| 출처 데이터셋 | uspto-grants-2006_05 |
| ORD ID | ord-bf5cf66e74654728ae3f1ed0d28ef6a6 |
| 출처 메모 | uspto-grants-2006_05 |